A Hidden Epidemic After COVID-19

                            A Hidden Epidemic After COVID-19 

 A Hidden Epidemic After COVID-19": Rise in Chronic Fatigue Cases in Germany

Experts in Germany have revealed a significant increase in the number of people with chronic fatigue syndrome (ME/CFS) since the beginning of the COVID-19 pandemic, amid warnings of a lack of medical awareness and the difficulty of treatment.

According to data from health insurance companies and specialized associations, approximately 600,000 people in Germany suffer from this chronic disease, scientifically known as myalgic encephalomyelitis (ME/CFS).

Carmen Scheibenbogen, director of the Charité Fatigue Center in Berlin for the Treatment of Chronic Fatigue, said that the numbers may have doubled during the pandemic, noting that the disease particularly affects young people.

The syndrome is characterized by symptoms that persist for more than six months, most notably extreme fatigue, difficulty concentrating, and sleep problems, along with worsening symptoms after any physical or mental exertion.

The disease has gained increased prominence during the COVID-19 pandemic due to its association with the phenomenon of "long COVID," as the syndrome can begin after a viral infection.

An international medical conference is being held in Berlin today, Monday, coinciding with World Chronic Fatigue Syndrome Day, with the participation of approximately 200 doctors and scientists, to discuss developments in the disease and ways to improve its management.

Scheibenbogen emphasized the importance of highlighting the shortage of medical supplies and medications for the syndrome and "long COVID," explaining that treatment options remain limited.

She also criticized the lack of adequate teaching of the syndrome in medical schools, which increases the need for specialized training programs.